title: International dosage differences in fluoxetine clinical trials.
abstract: OBJECTIVE
  International differences are thought to exist in dosages used by clinicians treating mood disorders. This study examined international dosage differences in antidepressant clinical trials, using a database formed and maintained as a component of a Cochrane review of comparative clinical trials of fluoxetine.
  
  
  METHODS
  This systematic review included 132 studies. A detailed set of methodological features and results were abstracted from the original publications and entered into an electronic database. Mean and maximum fluoxetine dosages were compared across countries. To evaluate the dosages of comparison medications, a defined daily dosage (DDD) ratio was calculated as the trial mean dosage divided by the DDD for that drug.
  
  
  RESULTS
  Both the maximum and mean dosages for fluoxetine and comparison medications were higher in trials conducted in the US (fluoxetine weighted mean dosage 49.18 mg; 95% CI, 41.30 to 57.05), compared with trials conducted in Europe (fluoxetine weighted mean dosage 29.98 mg; 95% CI, 25.28 to 34.68). Since most clinical trials were conducted in Europe or the US, we could not determine whether different dosages tended to be used in other regions.
  
  
  CONCLUSIONS
  International differences in prescriber behaviour may influence, and in turn be influenced by, the conduct of clinical trials. It is difficult to reconcile such differences with the principles of evidence-based medicine.
authors.affiliation: Department of Community Health Sciences, University of Calgary, Alberta.
authors.forename: Scott
authors.initials: S
authors.lastname: Patten
authors.forename: Andrea
authors.initials: A
authors.lastname: Cipriani
authors.forename: Paolo
authors.initials: P
authors.lastname: Brambilla
authors.forename: Michela
authors.initials: M
authors.lastname: Nosè
authors.forename: Corrado
authors.initials: C
authors.lastname: Barbui
mesh_terms: D004334:Drug Administration Schedule; D011307:Drug Prescriptions; D005060:Europe; D005473:Fluoxetine / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D019964:Mood Disorders / Q000188:drug therapy*; D016032:Randomized Controlled Trials as Topic; D017367:Selective Serotonin Reuptake Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use*; D014481:United States
chemical_list: D005473:Fluoxetine; D017367:Selective Serotonin Reuptake Inhibitors